IN2014DN09621A - - Google Patents

Download PDF

Info

Publication number
IN2014DN09621A
IN2014DN09621A IN9621DEN2014A IN2014DN09621A IN 2014DN09621 A IN2014DN09621 A IN 2014DN09621A IN 9621DEN2014 A IN9621DEN2014 A IN 9621DEN2014A IN 2014DN09621 A IN2014DN09621 A IN 2014DN09621A
Authority
IN
India
Prior art keywords
protein
sterilized
radiation
activity
function
Prior art date
Application number
Other languages
English (en)
Inventor
Yukako Kageyama
Kentaro Fujinaga
Ayuko Yamaguchi
Susumu Honda
Makoto Satake
Hiroaki Kaneko
Ayumi Ishiwari
Original Assignee
Teijin Ltd
Teijin Pharma Ltd
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd, Teijin Pharma Ltd, Chemo Sero Therapeut Res Inst filed Critical Teijin Ltd
Publication of IN2014DN09621A publication Critical patent/IN2014DN09621A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4833Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01021Beta-glucosidase (3.2.1.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21005Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003Triacylglycerol lipase (3.1.1.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Moulding By Coating Moulds (AREA)
IN9621DEN2014 2012-05-14 2013-05-13 IN2014DN09621A (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2012110390 2012-05-14
JP2012110765 2012-05-14
JP2013040593 2013-03-01
PCT/JP2013/063868 WO2013172468A1 (ja) 2012-05-14 2013-05-13 滅菌組成物

Publications (1)

Publication Number Publication Date
IN2014DN09621A true IN2014DN09621A (fi) 2015-07-31

Family

ID=49583866

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9621DEN2014 IN2014DN09621A (fi) 2012-05-14 2013-05-13

Country Status (18)

Country Link
US (1) US10071061B2 (fi)
EP (1) EP2851085B1 (fi)
JP (1) JP5746430B2 (fi)
KR (1) KR102037555B1 (fi)
CN (1) CN104284673B (fi)
AU (1) AU2013261308B2 (fi)
BR (1) BR112014028443B1 (fi)
CA (1) CA2873602C (fi)
DK (1) DK2851085T3 (fi)
ES (1) ES2746300T3 (fi)
HK (1) HK1204947A1 (fi)
IN (1) IN2014DN09621A (fi)
MX (1) MX356545B (fi)
PL (1) PL2851085T3 (fi)
PT (1) PT2851085T (fi)
RU (1) RU2695522C2 (fi)
TW (1) TWI636799B (fi)
WO (1) WO2013172468A1 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY173719A (en) 2012-05-14 2020-02-18 Teijin Pharma Ltd Formed sheet product and hemostatic material
JP6825913B2 (ja) 2014-04-30 2021-02-03 マトケ・ホールディングス・リミテッド 抗菌組成物
AU2016214119B2 (en) * 2015-02-03 2020-10-22 Matoke Holdings Limited Antimicrobial fibers and compositions
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
WO2020158833A1 (ja) 2019-01-31 2020-08-06 セルメディシン株式会社 無機塩類タンパク複合医療機器

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209937B (en) 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
JPH0622570B2 (ja) * 1989-01-31 1994-03-30 多木化学株式会社 生体材料
US5439688A (en) 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
US5225205A (en) 1989-07-28 1993-07-06 Debiopharm S.A. Pharmaceutical composition in the form of microparticles
CH679207A5 (fi) 1989-07-28 1992-01-15 Debiopharm Sa
CA2033046C (en) 1990-01-12 1999-08-03 Lowell Saferstein Process for preparing a neutralized oxidized cellulose product and its method of use
ATE142460T1 (de) * 1991-06-21 1996-09-15 Genetics Inst Osteogene proteine enthaltende arzneimittel
CH683149A5 (fr) 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
GB9206509D0 (en) 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges containing active agents
US5730933A (en) 1996-04-16 1998-03-24 Depuy Orthopaedics, Inc. Radiation sterilization of biologically active compounds
US5945128A (en) 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
GB2344519B (en) 1998-12-07 2004-05-19 Johnson & Johnson Medical Ltd Sterile therapeutic compositions
PL2079767T3 (pl) 2006-10-11 2015-05-29 Tolmar Therapeutics Inc Wytwarzanie biodegradowalnych poliestrów z właściwościami niskiego wyrzutu przez ekstrakcję płynem nadkrytycznym
US8076448B2 (en) 2006-10-11 2011-12-13 Tolmar Therapeutics, Inc. Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
KR20100052499A (ko) * 2007-08-01 2010-05-19 에디컨인코포레이티드 콜라겐-관련 펩티드 및 이의 용도
AR074603A1 (es) * 2008-12-15 2011-01-26 Novartis Ag Formulacion de deposito de octreotida con niveles de exposicion constantemente altos.uso. metodo. kit
EP2340785B1 (en) * 2009-03-10 2016-05-18 Medprin Regenerative Medical Technologies Co., Ltd. Artificial dura mater and manufacturing method thereof
JP5555928B2 (ja) * 2009-08-28 2014-07-23 日本バイリーン株式会社 酵素含有ナノファイバーの製造方法、酵素含有ナノファイバー、この酵素含有ナノファイバーを含む不織布及びこの不織布を用いた反応装置
JP5479584B2 (ja) * 2010-05-07 2014-04-23 帝人株式会社 生体糊用補強材及びその製造方法
US8273369B2 (en) * 2010-05-17 2012-09-25 Ethicon, Inc. Reinforced absorbable synthetic matrix for hemostatic applications
BR112012030455B1 (pt) * 2010-06-01 2021-08-17 Baxter Healthcare S.A. Processo para fabricar uma composição hemostática seca e estável, recipiente acabado final, e, kit para administrar uma composição hemostática
JP5792442B2 (ja) * 2010-09-01 2015-10-14 帝人株式会社 細胞特異的ペプチドを含有する繊維構造体

Also Published As

Publication number Publication date
BR112014028443A8 (pt) 2018-02-06
ES2746300T3 (es) 2020-03-05
MX356545B (es) 2018-06-01
RU2014150498A (ru) 2016-07-10
EP2851085B1 (en) 2019-06-26
PL2851085T3 (pl) 2019-12-31
BR112014028443B1 (pt) 2021-01-19
BR112014028443A2 (pt) 2017-06-27
DK2851085T3 (da) 2019-09-09
PT2851085T (pt) 2019-10-11
CN104284673A (zh) 2015-01-14
HK1204947A1 (en) 2015-12-11
US10071061B2 (en) 2018-09-11
CA2873602C (en) 2022-08-16
KR102037555B1 (ko) 2019-10-28
JP5746430B2 (ja) 2015-07-08
WO2013172468A1 (ja) 2013-11-21
AU2013261308A1 (en) 2014-12-04
TW201350147A (zh) 2013-12-16
KR20150023253A (ko) 2015-03-05
MX2014013818A (es) 2015-05-11
JPWO2013172468A1 (ja) 2016-01-12
TWI636799B (zh) 2018-10-01
EP2851085A4 (en) 2015-04-15
RU2695522C2 (ru) 2019-07-23
CA2873602A1 (en) 2013-11-21
AU2013261308B2 (en) 2018-02-08
EP2851085A1 (en) 2015-03-25
US20150125511A1 (en) 2015-05-07
CN104284673B (zh) 2018-02-13

Similar Documents

Publication Publication Date Title
CA144129S (en) Animal containment cage
MX2016008448A (es) Conjugados de var2csa-farmaco.
MY192475A (en) Modified factor ix polypeptides and uses thereof
PH12014501844B1 (en) Peptidomimetic macrocycles
MY167585A (en) Disposable diaper
GEP20196964B (en) Pest control composition including novel iminopyridine derivative
IN2014DN06812A (fi)
UY34721A (es) Anticuerpos anti-hla-b*27 y usos de éstos.
IN2014DN09159A (fi)
UY34484A (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
EP2805442A4 (en) TECHNIQUES FOR GENERATING OUTGOING MESSAGES ON THE BASIS OF LANGUAGE, INTERNATIONALIZATION AND LOCALIZATION PREFERENCES OF THE RECIPIENT
MY165759A (en) Pull-on diaper
UA110103C2 (uk) Модифікований туберкульозний антиген
MX359769B (es) Metodos para descelularizar huesos.
DK3281607T3 (da) Implanterbar protese med acellulære vævsvedhæftninger.
AU339376S (en) Sterilizing case
MX346786B (es) Polipeptidos de relaxina modificados y sus usos.
MY166103A (en) Disposable diaper
EP2575452A4 (en) ANTIMICROBIAL COMPOSITIONS
MX357675B (es) Anticuerpos anti-jagged y métodos de uso.
MX2016005285A (es) Conjugados de somatostatina y sus analagos.
IN2014DN09621A (fi)
EA201390654A1 (ru) Новый вариант антигемофилического фактора viii, обладающего повышенной специфической активностью
UA65243U (ru) Применение радиоактивного цисплатина как вещества с усиленным противоопухолевым действием
UA79010U (ru) Применение n -стеароилэтаноламина в качестве вещества с активным антигриппозным действием